Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products

Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription... J. Med. Toxicol. (2017) 13:303–308 DOI 10.1007/s13181-017-0622-8 ORIGINAL ARTICLE Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products 1 1 David Goldberger & David Vearrier Received: 5 January 2017 /Revised: 5 June 2017 /Accepted: 10 June 2017 /Published online: 14 July 2017 American College of Medical Toxicology 2017 Abstract 2013 with more cases being categorized as Bmajor effect^ Introduction In 2014, the US Food and Drug Administration and fewer cases being categorized as Bno effect.^ limited the production of prescription acetaminophen-opioid Conclusions The Food and Drug Administration limitation on combination products to 325 mg per dose unit. The goal of acetaminophen content per dose unit in opioid combination this mandate was to decrease the likelihood of unintentional products did not reduce the occurrence of unintentional acetaminophen hepatotoxicity. This study was designed to acetaminophen-induced hepatotoxicity or N-acetylcysteine determine if this federal regulation has succeeded in reducing administration as reported to NPDS. unintentional acetaminophen-induced hepatotoxicity from . . opioid combination products. Keywords Acetaminophen Hepatotoxicity Food and Drug Methods Using data from the National Poison Data System Administration Drug dosing limits (NPDS), we analyzed all calls to US Poison Control Centers in the years 2013 and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Toxicology Springer Journals

Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products

Loading next page...
 
/lp/springer_journal/evaluation-of-a-food-and-drug-administration-mandate-to-limit-PhmFCSNXYl
Publisher
Springer US
Copyright
Copyright © 2017 by American College of Medical Toxicology
Subject
Biomedicine; Pharmacology/Toxicology; Biomedicine, general
ISSN
1556-9039
eISSN
1937-6995
D.O.I.
10.1007/s13181-017-0622-8
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial